首页> 外文OA文献 >Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study.
【2h】

Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study.

机译:通过治疗高脂血症预防冠状动脉粥样硬化的进展:一项为期七年的前瞻性血管造影研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The progression of coronary atherosclerosis was assessed by repeat angiography in 28 patients and 20 controls with hyperlipidaemia (serum cholesterol concentration greater than 7.2 mmol/l (278 mg/100 ml) or serum triglyceride concentration greater than 2.0 mmol/l (177 mg/100 ml), or both) and symptomatic coronary artery disease of two or three vessels. Twenty eight patients (26 men and two women) were treated with diet and drugs (clofibrate or nicotinic acid, or both) to lower lipid concentrations. Twenty men taking part in a simultaneous study served as non-randomised controls. They received medical treatment for coronary artery disease but no treatment to reduce lipid concentrations. The initial levels of coronary risk factors and the angiographic state were comparable in the two groups. In the 28 patients total cholesterol, total triglyceride, and low density lipoprotein cholesterol concentrations were reduced by an average 18%, 38%, and 19% respectively by treatment for hyperlipidaemia and high density lipoprotein cholesterol concentration was increased on average by 10%. The treatment maintained these concentrations during a follow up of seven years. By all criteria coronary lesions progressed significantly less in the patients than the controls: the angiographic state remained completely unchanged in nine (32%) of the patients compared with only one (8%) of the surviving controls; of the arterial segments at risk, 46 (16.5%) progressed in the patients compared with 50 (38.2%) in the controls (p less than 0.001); and the coronary obstruction increased less in patients than in controls (p less than 0.05). Cardiac survival was 89% in seven years in the patients compared with 65% in five years in the controls (p less than 0.01). The anginal symptoms diminished or remained stable in 16 of the 24 patients who survived until the end of the study. The progression of coronary atheromatosis was significantly greater in those patients who during the seven years of treatment had an average total cholesterol concentration, VLDL plus LDL cholesterol concentration, or ratio of LDL to HDL cholesterol concentration above the respective median value than in those with the corresponding values below median. On the other hand, the patients with HDL cholesterol concentrations above the median during treatment showed less progression than those with lower HDL cholesterol concentrations. The increase in coronary obstruction was inversely related to the average HDL cholesterol concentration during treatment. The progression was not, however, related to LDL cholesterol concentration during treatment.(ABSTRACT TRUNCATED AT 400 WORDS)
机译:通过重复血管造影评估28例高脂血症(血清胆固醇浓度大于7.2 mmol / l(278 mg / 100 ml)或血清甘油三酸酯浓度大于2.0 mmol / l(177 mg / 100)的患者和20名对照的冠状动脉粥样硬化进展ml或两者兼有)和两三个血管的症状性冠状动脉疾病。用饮食和药物(氯贝酸或烟酸,或两者兼有)治疗二十八名患者(26名男性和两名女性)以降低血脂浓度。参加同步研究的20名男性作为非随机对照。他们接受了冠状动脉疾病的药物治疗,但未接受降低血脂浓度的治疗。两组的冠状动脉危险因素和血管造影状态的初始水平相当。通过高脂血症的治疗,在这28例患者中,总胆固醇,总甘油三酸酯和低密度脂蛋白胆固醇浓度分别平均降低18%,38%和19%,而高密度脂蛋白胆固醇浓度平均升高10%。在7年的随访中,治疗维持了这些浓度。从所有标准来看,患者的冠状动脉病变进展均明显少于对照组:9例(32%)患者的血管造影状态完全保持不变,而幸存的对照组只有1例(8%)。在有风险的动脉节段中,患者进展为46(16.5%),而对照组为50(38.2%)(p小于0.001);患者的冠状动脉阻塞增加少于对照组(p小于0.05)。患者的心脏存活率在7年中为89%,而在对照组中5年中为65%(p小于0.01)。在研究结束前存活的24例患者中,有16例的心绞痛症状减轻或保持稳定。在治疗的7年中,平均总胆固醇浓度,VLDL加LDL胆固醇浓度或LDL与HDL胆固醇浓度之比高于各自中位数的患者中,冠状动脉粥样硬化的进展明显高于相应水平的患者。值低于中位数。另一方面,与HDL胆固醇浓度较低的患者相比,HDL胆固醇浓度高于中位治疗的患者进展较慢。冠状动脉阻塞的增加与治疗期间平均HDL胆固醇浓度成反比。然而,进展与治疗期间的低密度脂蛋白胆固醇浓度无关。(摘要截短为400字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号